Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-30

Clinical Trial Update: Oral Immunotherapy for Peanut Allergic Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 oral immunotherapy trial for peanut allergy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oral peanut immunotherapy (investigational)

Snippet

Sponsor: InnoUp Farma S.L. | Conditions: Peanut Allergy | Phase 1, Phase 2 | Status: RECRUITING